🔗 Share this article

Given that the United States undertakes historic revisions to its immunization guidelines, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who rose to prominence by casting doubt on Covid vaccines during the pandemic and has concentrated on potential fatalities following Covid immunization in her short position at the FDA.

Proposed Overhauls to Childhood Vaccine Program

Health officials planned to reveal major changes to the pediatric vaccination calendar earlier this month, synchronizing the US with Denmark’s vaccine program, sources say – a significant shift that would place the US at odds with many the world with insufficient data for public health gain. This reveal has been pushed back until the coming year.

In place of Vinay Prasad, Dr. Høeg is set to speak at the gathering. She was just designated interim head of the FDA’s drug evaluation center, the fifth appointee to head the center this year.

A Shift at the FDA

The acting appointment might represent a strengthened alliance between the drug and biologics divisions as Høeg and Dr. Prasad strengthen their influence at the agency – and it suggests a renewed priority upon dismantling already-approved immunizations at the FDA.

The new acting director has often pushed for ending specific childhood shot schedules in the US to become more similar to Denmark, a nation with nationalized medicine and a population roughly the size of Wisconsin’s.

So far public appearances, she has kept her attention on vaccination policy – usually the purview of Prasad, chief of the FDA’s vaccine center – as opposed to medication approval.

Concerns Over Expertise

Dr. Høeg has no obvious experience in pharmaceutical research, oversight or leadership, which has been customary for past leaders of the biologics center. She has served at the FDA as a key advisor to the agency head and CBER since spring.

“She doesn’t seem to have the necessary background” for leading the CDER, stated a neurologist and psychiatrist. “She lacks experience running a clinical trial. She is not versed in managing a large organization. She has no expertise in drug approvals.”

Former heads of the center would “be deeply familiar with laws and regulations and the underlying principles of pharmaceutical innovation”, said a former acting FDA commissioner. “Frankly, she doesn’t have the type of experience that former directors who ran the center have had.”

The drug center has an enormous range of responsibilities at the FDA, she pointed out.

“The public just pays attention on the novel medication approvals, but the generic drug division approves numerous generic medications. There’s a biosimilars division, non-prescription drug unit and so forth, and all of those need to be supervised,” she explained. “The thing you overlook, that is the part that I always told people is going to bite you.”

Furthermore, a major administrative element to the role, which manages in excess of 5,000 staff members. “It’s a enormous administrative position, if you execute it properly,” she concluded.

Agency Reaction and Contentious Programs

Regarding inquiries about Høeg’s qualifications and whether this selection signifies increased cooperation among FDA leaders on vaccines, a press secretary stated that the “inquiries are based on flawed assumptions”.

“Her resume matches the functions of her role,” the official stated, noting the months Dr. Høeg spent counseling the FDA commissioner on “medication safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

In her interim role, Dr. Høeg assumes responsibility for the commissioner’s new expedited review system, a controversial one-day drug-approval program that reportedly worried her former heads. “By what process are these therapies being selected for this fast-track system? Who is making the decisions?” Howard said. “There’s a lot of secrecy going on at the agency right now.”

Broadly speaking, he stated, “the Food and Drug Administration looks to be trending towards less stringent oversight of all drugs, except for shots.”

Documented History on Immunizations

Concerning immunizations, Dr. Høeg has a more established, if concerning, track record, some experts said. She authored a research paper using unverified volunteer-provided data to determine the frequency of myocarditis after Covid vaccination. She advised the state of Florida top health official Joseph Ladapo, who was said to have changed statistics to imply Covid vaccinations are more dangerous than they are.

Included in her “wish list” for the current administration featured altering rules for recently developed shots and halting “unnecessary” immunizations, she said after the election on a podcast. At the agency, Høeg has according to sources floated the idea of preventing adolescent males from receiving Covid vaccinations.

“She is an all-around true believer who commences with her preconceived notions and tailors the evidence to retrofit the science in a highly disingenuous, fraudulent manner,” Dr. Howard stated.

Gaining Influence and a “Push for Payback”

Dr. Høeg aligned with other skeptics, {like|